Stifel Reiterates Equillium (EQ) at Buy, Initial Take on Bioniz Acquisition is Positive, May Generate Extensive Synergies, All-Stock Transaction is Logica
Tweet Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Buy rating on Equillium (NASDAQ: EQ), following announcement of acquisition of Bioniz.The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
